Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 11/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | LOX | P28300 | 1/20 | 0.39 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ACSS2 | Q9NR19 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13069425 | 0.87 | ALDH1A1 (0.47) | ALDH1A1HTTCA2POLBLOX | |
| SCHEMBL12810147 | 0.84 | ALDH1A1 (0.44) | ALDH1A1HTTPOLBPTGDR2CYP3A4 | |
| SCHEMBL13392068 | 0.83 | ALDH1A1 (0.44) | ALDH1A1HTTCA2LOXCYP3A4 | |
| SCHEMBL9338995 | 0.80 | CA2 (0.67) | ALDH1A1CA2POLBLOXCYP2C9 | |
| SCHEMBL10262158 | 0.80 | ALDH1A1 (0.44) | ALDH1A1CA2CYP2C9CYP2C19KDM4E | |
| SCHEMBL13391990 | 0.79 | ALDH1A1 (0.48) | ALDH1A1HTTCA2POLBKDM4E | |
| SCHEMBL27957276 | 0.78 | ALDH1A1 (0.43) | ALDH1A1CA2CYP2C9CYP2C19KDM4E | |
| SCHEMBL130972 | 0.78 | CA2 (0.53) | ALDH1A1HTTCA2POLBLOX | |
| SCHEMBL14495147 | 0.77 | L3MBTL1 (0.46) | ALDH1A1 | |
| SCHEMBL10646225 | 0.77 | CA2 (0.54) | ALDH1A1CA2POLBLOXCYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8372161-B2 | Method for the reactive coloring of leather | BASF SE (DE) | 2013-02-12 | — | — | US | disclosed |
| US-20090098074-A1 | Keratin-Binding Effector Molecules Containing Reactive Dyes | BASF SE (DE) | 2009-04-16 | — | — | US | disclosed |
| US-20070033746-A1 | Method for the reactive coloring of leather | BASF AKTIENGESSELLSCHAFT (DE) | 2007-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090098074-A1 | Keratin-Binding Effector Molecules Containing Reactive Dyes | KRT18, KLK3, KLKB1 | ALDH1A1 2661/4885HTT 2734/4885CA2 2620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.